Online citations, reference lists, and bibliographies.

Pathology Of Acute And Chronic Coronary Stenting In Humans.

Andrew Farb, Giuseppe Sangiorgi, Andrew James Carter, Virginia M. Walley, William D. Edwards, Robert S. Schwartz, Renu Virmani
Published 1999 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Despite the increasing use of stents, few reports have described human coronary artery morphology early and late after stenting. METHODS AND RESULTS Histology was performed on 55 stents in 35 coronary vessels (32 native arteries and 3 vein grafts) from 32 patients. The mean duration of stent placement was 39+/-82 days. Fibrin, platelets, and neutrophils were associated with stent struts 20 associated inflammatory cells compared with 44% of struts embedded in a lipid core and 36% of struts in contact with damaged media (P<0.001). Neointimal growth determined late histological success, and increased neointimal growth correlated with increased stent size relative to the proximal reference lumen area. Neointimal thickness was greater for struts associated with medial damage than struts in contact with plaque (P<0.0001) or intact media (P<0.0001). When matched for time since treatment, neointimal cell density in stented arteries was similar to that in unstented arteries that had undergone balloon angioplasty and showed similar proteoglycan deposition. CONCLUSIONS Morphology after coronary stenting demonstrates early thrombus formation and acute inflammation followed by neointimal growth. Medial injury and lipid core penetration by struts result in increased inflammation. Neointima increases as the ratio of stent area to reference lumen area increases. Deployment strategies that reduce medial damage and avoid stent oversizing may lower the frequency of in-stent restenosis.
This paper references
10.1016/0735-1097(94)90126-0
Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model.
Andrew James Carter (1994)
10.1016/0735-1097(92)90494-8
Vascular pathology of balloon-expandable flexible coil stents in humans.
Peter G. Anderson (1992)
10.1016/0735-1097(93)90715-D
Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation.
Heleen M. M. van Beusekom (1993)
10.1161/01.CIR.98.3.224
Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.
Ryushi Komatsu (1998)
10.1016/0735-1097(92)90476-4
Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model.
Robert S. Schwartz (1992)
10.1016/s0735-1097(96)81890-0
Initial and six months outcome of Palmaz-Schatz stent implantation: Stress/Benestent equivalent vs non-equivalent lesions
Yoshihiro Sawada (1996)
10.1016/0735-1097(94)90589-4
Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment.
Albert Schoemig (1994)
10.1161/01.CIR.91.12.2995
Endovascular stent design dictates experimental restenosis and thrombosis.
C Rogers (1995)
10.1056/NEJM199408253310801
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
P. W. Serruys (1994)
10.1016/0735-1097(95)00574-9
Three-year clinical follow-up after Palmaz-Schatz stenting.
Bruce D. Klugherz (1996)
10.1056/NEJM199408253310802
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
David L Fischman (1994)
10.1016/0735-1097(95)00584-6
Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model.
Andrew James Carter (1996)
Three - year clinical follow - up after PalmazSchatz stenting
BD Klugherz (1996)
10.1161/01.ATV.16.10.1312
Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin.
C Rogers (1996)
10.1016/S0002-9149(97)89326-5
"Bailout" coronary stenting in patients with a recent myocardial infarction.
Clifford N Thomas (1996)



This paper is referenced by
10.1080/14779072.2018.1435274
The evolution of coronary stents
P. Mckavanagh (2018)
10.1053/euhj.2001.2609
The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial.
Rainer Hoffmann (2001)
10.1253/circj.70.1026
Myocardial infarction as a presentation of clinical in-stent restenosis.
Atasu K Nayak (2006)
10.1007/s00270-001-1729-4
Nonbiodegradable Expanded Polytetrafluoroethylene-Covered Stent Implantation in Porcine Peripheral Arteries: Histologic Evaluation of Vascular Wall Response Compared with Uncoated Stents
Giuseppe Sangiorgi (2001)
Stent-Sizing With Intravascular Ultrasound ontributes to Complete Neointimal Coverage fter Sirolimus-Eluting Stent Implantation ssessed by Angioscopy
usako Sera ()
Comparison of restenosis rates of two coronary stent systems with different active coating
Najib Al-Abdulrazzak (2005)
10.1016/j.rec.2015.02.028
Safety and Efficacy of New Sirolimus-eluting Stent Models in a Preclinical Study.
Rodrigo Estévez-Loureiro (2015)
10.1007/s15027-014-0358-1
In-Stent-Neoatherosklerose nach perkutaner Koronarintervention
Sebastian Kufner (2014)
10.1093/eurheartj/ehi098
Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.
Jürgen Pache (2005)
10.1016/j.actbio.2014.10.029
Elastin-like recombinamer-covered stents: Towards a fully biocompatible and non-thrombogenic device for cardiovascular diseases.
Israel González de Torre (2015)
10.3349/ymj.2014.55.4.944
Optical Coherence Tomographic Observation of Morphological Features of Neointimal Tissue after Drug-Eluting Stent Implantation
Seung-Yul Lee (2014)
10.1007/s13239-015-0219-9
Sequential Structural and Fluid Dynamics Analysis of Balloon-Expandable Coronary Stents: A Multivariable Statistical Analysis
David Martín (2015)
10.1097/MJT.0000000000000309
Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction
Azadeh Eshraghi (2016)
10.3904/kjim.2011.26.1.41
Two-Year Clinical Outcome after Carvedilol-Loaded Stent Implantation in Patients with Coronary Artery Disease
Hyun Kuk Kim (2011)
10.1161/ATVBAHA.112.247874
Role of adenosine in response to vascular inflammation.
Joel Linden (2012)
Diet-induced dyslipidemia drives store-operated Ca2+ entry, Ca2+ dysregulation, non-alcoholic steatohepatitis, and coronary atherogenesis in metabolic syndrome
Zachary P. Neeb (2010)
CORONARY STENT EVOLUTION – FROM PATHOLOGY TO CLINIC
Oscar David Sánchez (2014)
10.1001/jama.295.11.1264
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
David R Holmes (2006)
Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997).
Paolo Angelini (2000)
10.4103/0366-6999.228247
Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention
Cheng-ping Hu (2018)
10.1161/CIRCULATIONAHA.118.035400
Role of Allergic Inflammatory Cells in Coronary Artery Disease.
Giampaolo Niccoli (2018)
Vergleich von Nominal- versus Hochdruckballoninflatation für optimale Koronarstent-Implantation durch IVUS und QCA mit EXPRESS™ Coronary Stent System
Raymund Gabriel A Naranjilla (2006)
Aterektomia przed wszczepieniem stentu - nowe nadzieje w walce z restenozą
Maciej Kośmider (2000)
Reestenosis, trombosis de stent y complicaciones hemorrágicas. Navegar entre Escila y Caribdis
Juan José Torrado (2018)
10.1586/14779072.1.3.393
Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases
Shiro Kitamoto (2003)
10.1007/s10439-015-1483-4
Haemodynamics and Flow Modification Stents for Peripheral Arterial Disease: A Review
Efstratios Kokkalis (2015)
10.1016/S1131-3587(13)70075-X
Antiagregación oral en el intervencionismo coronario percutáneo: fármacos disponibles y duración de la terapia oral
José Luis Lamas Ferreiro (2013)
10.3109/14653249.2010.548378
Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice.
Juliana A. P. Godoy (2011)
10.1160/TH10-11-0698
Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.
Michael D. Joner (2011)
10.1016/j.jacc.2009.10.070
Understanding the role of endothelial progenitor cells in percutaneous coronary intervention.
Gareth J. Padfield (2010)
10.4244/EIJ30V6I4A79
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
Parham Eshtehardi (2010)
10.1016/B978-0-08-100496-8.00001-9
Overview of cardiovascular stent designs
Christopher McCormick (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar